2019 American Transplant Congress
Contribution of CD38 to Methionine Choline Deficient (MCD) Diet-Induced Liver Injury in Rats
Department of Cardiac Surgery, The Ohio State Univ. Medical Center, Columbus, OH
*Purpose: Nonalcoholic fatty liver disease (NAFLD) and associated non-alcoholic steatohepatitis (NASH) is a rising cause of end stage liver disease, increasing the need for liver…2019 American Transplant Congress
Treatment of Cardiovascular Risk Factors Improves Long Term Outcome Post Liver Transplantation
Washington University in St Louis, Saint Louis, MO
*Purpose: Cardiovascular (CV) disease is a leading cause of mortality 1 year after liver transplantation (LT). We aimed to assess the effect of treating CV…2019 American Transplant Congress
BMI Influence on the Outcomes of Renal Transplant
*Purpose: Our aim was to assess the effect of body mass index (BMI) on the outcomes of renal transplant and the management of obese patients…2019 American Transplant Congress
The Comparison of Glycemic Profiles during Post-Operative Early Period between Liver and Kidney Transplantation Assessed by Continuous Glucose Monitoring System
*Purpose: Newly developed hyperglycemia and worsening of previously well controlled glucose control are common after transplantation because of stressful condition and immunosuppressive agents including of…2019 American Transplant Congress
Metabolic Liver Transplantation – Can We Afford It?
*Purpose: Despite major improvement in medical and nutritional care of pediatric patients suffering from intoxication inherited metabolic disorders, their long term outcomes remain guarded. Liver…2019 American Transplant Congress
Living Donor vs. Deceased Donor Liver Transplantation for Pediatric Patients with Metabolic Liver Disease
Renji Hospital, Shanghai, China
*Purpose: Liver transplantation has been accepted as the appropriate treatment option for pediatric metabolic liver disease and the most common methods used are LDLT and…2019 American Transplant Congress
Metabolic Liver Transplant: A Single Cooperative 2002-2017
*Purpose: Liver transplant (LT) can increase quality and quantity of life for patients with inherited metabolic diseases (IMDs) who suffer severe and unpredictable complications despite…2019 American Transplant Congress
Pediatric Liver Transplantation for Metabolic Disorders without Intrinsic Liver Disease: A 25 Year Experience
Stanford University Medical Center, Palo Alto, CA
*Purpose: Liver transplantation (LT) for acute and chronic end-stage-liver-disease is a well-accepted therapy in pediatrics. However, for children with metabolic disorders (MD) without intrinsic liver…2019 American Transplant Congress
Long-Term Outcomes in Patients with Obesity and Renal Disease after Sleeve Gastrectomy
Department of Surgery, University of Cincinnati, Cincinnati, OH
*Purpose: Morbid obesity is a barrier to kidney transplantation in patients with end-stage renal disease (ESRD) and is associated with progression of chronic kidney disease…2019 American Transplant Congress
Comparison of Two Glucagon-Like-Peptide-1 Analogs (GLP -1) Dulaglutide vs Liraglutide for the Management of Diabetes in Solid Organ Transplant (SOT)
Ohio State University, Columbus, OH
*Purpose: Poorly controlled Type-2 diabetes is an important contributor to graft dysfunction, and cardiovascular morbidity in the SOT. GLP-1-analog has been widely used in the…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- 8
- Next Page »